๐Ÿ•ต๏ธ AMN Healthcare Services Inc ($AMN)

SEC insider & ownership activity, last 12 months ยท CIK 1142750 ยท every row links its SEC filing

Over the last 12 months insiders sold $114K with no open-market buying against it. Mark G. Foletta sold $114K through a 10b5-1 trading plan in 2 lots (Jun). No red-flag 8-Ks in the window.

Aug 2025: net +$0 Sep 2025: net +$0 Oct 2025: net +$0 Nov 2025: net +$0 Dec 2025: net +$0 Jan 2026: net +$0 Mar 2026: net +$0 Mar 2026: net +$0 Apr 2026: net +$0 May 2026: net +$0 Jun 2026: net -$114K Jul 2026: net +$0
Monthly net open-market insider flow, last 12 months (up = net buying)

Insider flow

0 buyers, $0 (0 lots) ยท 1 seller, $114K (2 lots)

InsiderBuysBoughtSellsSoldLast
Mark G. Foletta0โ€“ 2$114KJun 15, 2026

5%+ holders

HolderStakeClassScheduleEvent
Blackrock, Inc. 15.3% 13GApr 30, 2025 filing โ†—
Millennium Management LLC 5.2% 13GFeb 12, 2026 filing โ†—
Millennium Group Management LLC 5.2% 13GFeb 12, 2026 filing โ†—
Israel A. Englander 5.2% 13GFeb 12, 2026 filing โ†—
Vanguard Capital Management 5.1% 13GApr 29, 2026 filing โ†—

Planned insider sales (Form 144)

SellerPlannedApprox. sale date
Mark G. Foletta$114KJun 15, 2026 filing โ†—

Material events (8-K)

ItemEvent date
Financial Statements and Exhibits (9.01)May 7, 2026 filing โ†—
Officer/director changes (5.02)May 1, 2026 filing โ†—
Shareholder vote (5.07)May 1, 2026 filing โ†—
Financial Statements and Exhibits (9.01)May 1, 2026 filing โ†—
Financial Statements and Exhibits (9.01)Feb 19, 2026 filing โ†—
Officer/director changes (5.02)Jan 30, 2026 filing โ†—
Reg FD disclosure (7.01)Jan 14, 2026 filing โ†—
Charter/bylaw changes (5.03)Dec 11, 2025 filing โ†—
Earnings (2.02)Nov 6, 2025 filing โ†—
Financial Statements and Exhibits (9.01)Nov 6, 2025 filing โ†—
Material agreement (1.01)Oct 6, 2025 filing โ†—
New financial obligation (2.03)Oct 6, 2025 filing โ†—
Other events (8.01)Oct 6, 2025 filing โ†—
Financial Statements and Exhibits (9.01)Oct 6, 2025 filing โ†—
Other events (8.01)Sep 22, 2025 filing โ†—
Financial Statements and Exhibits (9.01)Sep 22, 2025 filing โ†—
Reg FD disclosure (7.01)Sep 22, 2025 filing โ†—
Earnings (2.02)Aug 7, 2025 filing โ†—
Financial Statements and Exhibits (9.01)Aug 7, 2025 filing โ†—